How many insider trades does FilingIQ track for PHIO?

FilingIQ tracks 112 Form 4 insider transactions for PHIO (Phio Pharmaceuticals Corp.), covering filings from Nov 23, 2018 onwards. 1 of those were filed in the last 90 days.

Are PHIO insiders net buyers or net sellers?

Across the full Form 4 history for PHIO, 30 transactions (27%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does PHIO insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is PHIO in?

Phio Pharmaceuticals Corp. (PHIO) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $15.51M.

PHIO insider trading

NasdaqCM Healthcare

Phio Pharmaceuticals Corp. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

112

Last 90 days

Buys / sells

27% / 0%

Market cap

$15.51M

About Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp., a clinical stage biopharmaceutical company, engages in the development of immuno-oncology therapeutics in the United States. It develops PH-762, an INTASYL compound designed to reduce the expression of PD-1 in multi-center Phase 1b dose-escalating clinical trials; PH-894, an INTASYL compound that is designed to specifically silence BRD4, a protein that controls gene expression in both T cells and tumor cells in preclinical studies. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was founded in 2003 and is based in King Of Prussia, Pennsylvania.

Company website: phiopharma.com

PHIO insider activity at a glance

FilingIQ has scored 112 insider transactions for PHIO since Nov 23, 2018. The most recent filing in our index is dated Jun 26, 2026.

Across the full history, 30 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on PHIO insider trades is 62.6/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live PHIO trades on FilingIQ Raw filings on SEC EDGAR

Latest PHIO Form 4 filings

Bitterman Robert J President & CEO

P Feb 26, 2024

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 274

Apellis Pharmaceuticals, Inc.

KYMR 234

Kymera Therapeutics, Inc.

GH 194

Guardant Health, Inc.

Frequently asked

How many insider trades does FilingIQ track for PHIO?: FilingIQ tracks 112 Form 4 insider transactions for PHIO (Phio Pharmaceuticals Corp.), covering filings from Nov 23, 2018 onwards. 1 of those were filed in the last 90 days.
Are PHIO insiders net buyers or net sellers?: Across the full Form 4 history for PHIO, 30 transactions (27%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does PHIO insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is PHIO in?: Phio Pharmaceuticals Corp. (PHIO) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $15.51M.

Methodology & sources

Every PHIO insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.